title: Chronic myeloid leukemia--some topical issues.
authors.forename: T
authors.initials: T
authors.lastname: Mughal
authors.forename: J
authors.initials: J
authors.lastname: Cortes
authors.forename: N C P
authors.initials: NC
authors.lastname: Cross
authors.forename: N
authors.initials: N
authors.lastname: Donato
authors.forename: O
authors.initials: O
authors.lastname: Hantschel
authors.forename: E
authors.initials: E
authors.lastname: Jabbour
authors.forename: H
authors.initials: H
authors.lastname: Kantarjian
authors.forename: J V
authors.initials: JV
authors.lastname: Melo
authors.forename: T
authors.initials: T
authors.lastname: Skorski
authors.forename: R T
authors.initials: RT
authors.lastname: Silver
authors.forename: J M
authors.initials: JM
authors.lastname: Goldman
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology; D016503:Drug Delivery Systems; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000209:etiology / Q000235:genetics*; D009363:Neoplasm Proteins / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D009363:Neoplasm Proteins; D016044:Fusion Proteins, bcr-abl